Bobak R. Azamian - 06 Aug 2021 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
President and CEO, Director
Signature
/s/ Leonard M. Greenstein, Attorney-in-Fact
Issuer symbol
TARS
Transactions as of
06 Aug 2021
Net transactions value
-$61,088
Form type
4
Filing time
10 Aug 2021, 16:53:10 UTC
Previous filing
06 Aug 2021
Next filing
12 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARS Common Stock Sale $40,400 -1,616 -0.13% $25.00 1,230,285 06 Aug 2021 By the Bobak Azamian Living Trust established April 16, 2018 F1, F2
transaction TARS Common Stock Sale $18,175 -727 -0.06% $25.00 1,229,558 09 Aug 2021 By the Bobak Azamian Living Trust established April 16, 2018 F1, F2
transaction TARS Common Stock Sale $2,513 -100 -0.01% $25.13 1,229,458 09 Aug 2021 By the Bobak Azamian Living Trust established April 16, 2018 F1, F2
holding TARS Common Stock 1,750 06 Aug 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021.
F2 The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.